The effect of D-cycloserine on social anxiety treatment using a behavioral outcome measure and a post-session administration strategy.

ABSTRACT:

Background

The drug D-Cycloserine (DCS) has been used as an adjunct to increase the pace of symptom reductions during exposure therapy for anxiety disorders. This procedure has met with mixed results andmany questions remain. Aims: The findings from two investigations are reported here, highlighting important domains for furthering our understanding of DCS effects.

Method

Study 1 (n = 16) treated social anxiety among a sample of emerging adults, and in addition to self-report utilized a behavioral measure of symptom improvement to evaluate outcomes. Study 2 (n = 16), utilizing a similar design, introduced an algorithm based post-session administration strategy following sessions where anxiety reductions were evident. Both investigations were double-blind, placebo controlled,

SUBMITTER: Sheerin CM 

PROVIDER: S-EPMC5155704 | biostudies-literature | 2016 Aug

REPOSITORIES: biostudies-literature